Skip to main content

Research

New research
Research history

Explore

Search
Cases
Professionals

Resources

Blog
Pricing
Docs

Sign in Create account

Cases

CourtFilingsPetition dateMore filters

Case

Funded debt

Stage

Exit

Next hearing

Last activity

Petition date

Court

Aralez Pharmaceuticals US Inc. Bankruptcy Case

Aralez Pharmaceuticals US Inc.

Sale Process

Case No. 18-12425·New York Southern·Petition date Aug 10, 2018

Research this case Track this case Sign in

OverviewProfessionals

Key professionals

Financial Advisor

Alvarez & Marsal Healthcare Industry Group, LLC

Financial Advisor

Berkeley Research Group

Financial Advisor

Dundon Advisers LLC

Investment Banker

Moelis & Company

Judge: Martin Glenn
Petition assets: $100M–$500M
Petition liabilities: $100M–$500M
Industry: Healthcare
Debtors: 7

Aralez Pharmaceuticals US Inc. is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of cardiovascular and specialty therapeutic products. Formed via a 2016 business combination of POZEN Inc. and Aralez Pharmaceuticals Canada Inc., the company operates with headquarters in Mississauga, Ontario, and maintains offices in New Jersey, New York, Pennsylvania, and Ireland. It employs 74 full-time staff globally and manages a portfolio including the Toprol-XL franchise, Zontivity, and Fibricor.

Case background, summaries, and key terms are generated from the filings on this docket. Docket entries and documents come from the court.

Report a data error